scholarly article | Q13442814 |
P50 | author | Viacheslav O. Nikolaev | Q59832454 |
P2093 | author name string | Ali El-Armouche | |
Julia H Steinbrecher | |||
Stephan E Lehnart | |||
Kai Schuh | |||
Marco Abesser | |||
Daniela Hübscher | |||
Julia U Sprenger | |||
Ruwan K Perera | |||
P433 | issue | 8 | |
P304 | page(s) | 1304-1311 | |
P577 | publication date | 2015-02-16 | |
P1433 | published in | Circulation Research | Q2599020 |
P859 | sponsor | Collaborative Research Centre (CRC) 1002: "Modulatory Units in Heart Failure" | Q48693816 |
P1476 | title | Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy | |
P478 | volume | 116 |
Q91646043 | A Software Tool for High-Throughput Real-Time Measurement of Intensity-Based Ratio-Metric FRET |
Q52641165 | Anticoagulation in atrial fibrillation with heart failure. |
Q28082833 | Atrial natriuretic peptide in cardiovascular biology and disease (NPPA) |
Q47987941 | C33(S), a novel PDE9A inhibitor, protects against rat cardiac hypertrophy through upregulating cGMP signaling |
Q64916187 | Constitutive inhibitory G protein activity upon adenylyl cyclase-dependent cardiac contractility is limited to adenylyl cyclase type 6. |
Q42486313 | Differences in the control of basal L-type Ca(2+) current by the cyclic AMP signaling cascade in frog, rat, and human cardiac myocytes. |
Q55379674 | Distinct submembrane localisation compartmentalises cardiac NPR1 and NPR2 signalling to cGMP. |
Q91178562 | FRET-based cyclic GMP biosensors measure low cGMP concentrations in cardiomyocytes and neurons |
Q38612665 | From bedside to bench--meeting report of the 7th International Conference on cGMP "cGMP: generators, effectors and therapeutic implications" in Trier, Germany, from June 19th to 21st 2015. |
Q38998559 | Global left atrial failure in heart failure |
Q26785322 | Imaging alterations of cardiomyocyte cAMP microdomains in disease |
Q49787366 | Imaging of PDE2- and PDE3-Mediated cGMP-to-cAMP Cross-Talk in Cardiomyocytes |
Q36270020 | Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway. |
Q37486049 | Interactions of Calcium Fluctuations during Cardiomyocyte Contraction with Real-Time cAMP Dynamics Detected by FRET. |
Q38862807 | Mechanisms of the cyclic nucleotide cross-talk signaling network in cardiac L-type calcium channel regulation |
Q38794203 | Molecular Physiology of Membrane Guanylyl Cyclase Receptors |
Q91930958 | Phosphodiesterase 5 Associates With β2 Adrenergic Receptor to Modulate Cardiac Function in Type 2 Diabetic Hearts |
Q36140769 | Recombinant Atrial Natriuretic Peptide Prevents Aberrant Ca2+ Leakage through the Ryanodine Receptor by Suppressing Mitochondrial Reactive Oxygen Species Production Induced by Isoproterenol in Failing Cardiomyocytes |
Q52809588 | Roles of A-Kinase Anchoring Proteins and Phosphodiesterases in the Cardiovascular System. |
Q36609843 | Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network |
Q102053331 | Selective changes in cytosolic β-adrenergic cAMP signals and L-type Calcium Channel regulation by Phosphodiesterases during cardiac hypertrophy |
Q37601816 | Sodium Ferulate Protects against Angiotensin II-Induced Cardiac Hypertrophy in Mice by Regulating the MAPK/ERK and JNK Pathways. |
Q89912914 | Studying signal compartmentation in adult cardiomyocytes |
Q89434361 | Targeting FRET-Based Reporters for cAMP and PKA Activity Using AKAP79 |
Q92461195 | Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond |
Q92070172 | Visualizing Cyclic Adenosine Monophosphate in Cardiac Microdomains Involved in Ion Homeostasis |
Q55004774 | cGMP Signaling in the Cardiovascular System-The Role of Compartmentation and Its Live Cell Imaging. |
Q54854883 | cGMP and cardiac hypertrophy. |
Search more.